Splice variant of IGF-1 expressed in skeletal muscle in response to mechanical load; research peptide.
Alternative splice isoform of IGF-1 (exon 4-5-6 arrangement unique to this variant). Endogenously produced in response to muscle damage; synthetic versions investigated for muscle repair.
Evidence summary in progress. See the citations section below for the underlying research papers.
No FDA label or editorial side-effect profile is on file for this compound yet. See the clinical trials and citations sections for study-reported safety data.
No documented drug interactions on file.
Not FDA approved. Research chemical only.
Not available via 503A/503B compounding pharmacies.
Regulatory data last verified 4/19/2026
Showing 12 of 25 indexed studies. View all on ClinicalTrials.gov →
Showing 20 of 30 papers. View all on PubMed →